Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

drug side effects

This page shows the latest drug side effects news and features for those working in and with pharma, biotech and healthcare.

US says medicine ads should include list prices

US says medicine ads should include list prices

Right now, drug companies are required to disclose the major side effects a drug can have – but not the effect that buying the drug could have on your wallet,” said the ... Azar told the National Academy of Medicine (NAM) that “for too long, drug

Latest news

  • GSK two-drug trial in untreated HIV raises Gilead rivalry GSK two-drug trial in untreated HIV raises Gilead rivalry

    for HIV – with few side effects and drug interactions. ... That’s one reason the results of the GEMINI trials in untreated HIV are so important to ViiV, giving it two-drug regimens to match Biktarvy across the board.

  • GSK sells eczema and psoriasis drug to Dermavant for £250m GSK sells eczema and psoriasis drug to Dermavant for £250m

    that could provide an alternative to topical and oral steroids, which have side effects. ... In phase II trials the drug had a dose-dependent impact on plaque psoriasis lesions, and it is ready to move to phase III testing.

  • ViiV’s two-drug HIV combo backed by CHMP ViiV’s two-drug HIV combo backed by CHMP

    pill, two-drug regimen with the opportunity to reduce the number of drugs needed to treat HIV”. ... At the moment most patients are treated with three-drug regimens, and ViiV says the two-drug regimens can reduce drug exposure and side effects, as well

  • It’s only money It’s only money

    drug by emphasising potential side effects. ... It is suspected that falsified data was used in the clinical trial of Novartis’s best selling drug Diovan.

  • BMS' Yervoy picks up another indication in Europe BMS' Yervoy picks up another indication in Europe

    found to be more effective than Yervoy with patients reporting a better PFS with fewer side effects. ... The European approval follows a decision by the US Food and Drug Administration’s (FDA) to approve the drug for the same indication back in July

More from news
Approximately 1 fully matching, plus 97 partially matching documents found.

Latest Intelligence

  • Redirecting your patient strategy Redirecting your patient strategy

    But when people are dealing with their condition for so long, it is important that you understand how they're actually managing it, how they're using the drug.”. ... These new companies have developed novel business models based on sharing the data and

  • Choices, choices: the rapidly evolving HIV treatment landscape Choices, choices: the rapidly evolving HIV treatment landscape

    IIs are more potent, with fewer side effects and drug interactions and the top reason for prescribing them is their good tolerability profile. ... As patients differ so do their barriers to adherence, whether this be complexity of the dosing regimen,

  • Patients First Patients First

    to their thoughts on the impact of drug side effects, these are all areas that pharma is already actively engaged with at some level.

  • Oncology drugs under AMNOG: part two Oncology drugs under AMNOG: part two

    The G-BA assesses drugs on four criteria: mortality; morbidity (for example, symptom improvement); quality of life; and adverse events (toxicity and side effects). . ... A natural question to ask is how the benefit finding impacts the final price of a

  • Country report: The healthcare market in China Country report: The healthcare market in China

    The National Development and Reform Commission (NDRC) is charged with defining drug pricing. ... Indeed, more than 50 per cent of 'netizens' in China use the internet to search for information on new medicines, including pricing, drug efficacy and side

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

  • What does social media listening actually tell us?

    They have experiences, opinions and ideas which could be used to improve both treatments and practices (such as reports of side effects and effective drug combinations, for example) – and the methods ... The limits and regulations which accompany the

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Quick links

Infographics

Multimedia